Johnson & Johnson

JNJ · NYSE · USD

$256.03Change from previous close: −1.02%Absolute change: −$2.63

Close · October 2, 2026

At a glance

Revenue growth
+6.05%
2025 vs 2024
Net income growth
+90.56%
2025 vs 2024
Net margin
28.5%
2024: 15.8%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Cash flow · Annual
Item2025202420232022202120202019201820172016
Operating cash flow24,53024,26622,79121,19423,41023,53623,41622,20121,05618,767
Depreciation and amortization7,5037,3397,1036,3296,6517,2317,0096,9295,6423,754
Capital expenditure-4,832-4,424-4,381-3,706-3,652-3,347-3,498-3,670-3,279-3,226
Investing cash flow-23,588-18,599878-12,371-8,683-20,825-6,194-3,167-14,868-4,761
Financing cash flow-5,539-3,132-15,825-8,871-14,047-6,120-18,015-18,510-7,673-8,551
Dividends paid-12,381-11,823-11,770-11,682-11,032-10,481-9,917-9,494-8,943-8,621
Share repurchases-5,953-2,432-5,054-6,035-3,456-3,221-6,746-5,868-6,358-8,979
Debt issued23,72421,93713,74316,1362,00210,82242.085.09,86112,115
Debt repaid-14,087-10,916-24,524-8,684-2,992-3,727-2,923-4,034-3,107-4,240
Effect of exchange rates201-289-112-312-17889.0-9.0-241337-215
Net change in cash-4,3962,2467,732-360502-3,320-802283-1,1485,240
Free cash flow19,69819,84218,41017,48819,758—————
Levered free cash flow16,63316,66619,95215,39615,77121,77324,80317,24717,90513,749